Skip to main content
New Year’s Sale — Build a balanced news diet with 40% off Vantage
Published loading...Updated

Atara Biotherapeutics Sees Its Stock Price Rise

The announcement by Atara Biotherapeutics Inc. that it was raising $36 million through a registered direct offering sat well with investors. Thousand Oaks-based drug company made the announcement after the market closed on Sept. 3. The following day the stock rose nearly 33% to end the day at $9.05. The increase in share price continued a trend of sorts in play for Atara since its 1:25 stock split on June 20. On that day the share price closed a…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.Cross Cancel Icon

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

labusinessjournal.com broke the news in on Monday, September 9, 2024.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal